Overexpression of hepatic pescadillo 1 in obesity induces lipid dysregulation by inhibiting autophagy

Jielin Zhou,Yao Lu,Yan Lin,Chengcheng Li,Juan Liu,Zhengxuan Jiang,Keyang Chen

DOI: https://doi.org/10.1016/j.trsl.2023.02.003

IF: 10.171

2023-02-12

Translational Research

Abstract:Previous studies indicated that increased hepatic pescadillo 1 (PES1) in type 2 diabetic mice was associated with lipid dysregulation. However, the role of PES1 in obesity-associated lipid dysregulation is still unknown. This study investigates the effects and underlying mechanism. Livers from obese and healthy human and mice were collected, and C57BL/6J mice were either fed on standard diet and high fat diet (HFD). McArdle 7777 rat hepatoma cells were treated with phosphate-buffered saline and oleic acid (OA)+ palmitic acid (PA), respectively. In vitro Pes1 knockdown or overexpression and in vivo Pes1 knockdown or liver-specific ablation or supplementation of Pes1 were used to explore the modulating role of PES1. We found that obesity in humans enhanced hepatic PES1 protein, accompanied by increased plasma TG. These data are consistent with those from OA+PA-treated cells and from HFD- or Pes1 overexpression-treated C57BL/6J mice. In vitro and in vivo Pes1 knockdown in cultured cells and in ob/ob mice promoted the expression of the autophagy markers (TFEB, Beclin1 and LC3B-II) while decreasing the p62 and TG, contrary to Pes1 overexpression in cells and in normal mice. Moreover, liver-specific knockout of Pes1 protected the mice fed on HFD from increased TG levels, facilitating the TFEB, Beclin1 and LC3B-II and curbing p62. Mechanistically, OA+PA increased C/EBPβ binding to the Pes1 promoter, leading to the elevation of PES1, and subsequently enhancing PES1-facilitated ubiquitination of TFEB. Our findings reveal that overexpression of hepatic PES1 in obesity may induce TG dysregulation by inhibiting autophagy.

medicine, general & internal,medical laboratory technology, research & experimental